To subscribe to our optical e-newsletters and receive them via e-mail, click here.
New compounds, especially those derived from hyaluronic acid, may change the game of dry-eye treatment.
Simple attributes, such as how much drug can reach its target and how long it stays there, make a big difference in outcomes.
A look at the science behind the development of lifitegrast, and where it fits into the therapeutic puzzle.
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
The placid ocular surface is actually teeming with life that might hold the secret to treating ophthalmic disease.
How to approach the occasional situation in which this chronic condition suddenly becomes acute.
The exciting world of stem cell therapy is the cutting edge of medical research. Here’s how it intersects with ophthalmology.
Learning more about ocular allergy has revealed a host of potential allergic mediators for researchers to attack.
Attempts to engineer contact lenses that also elute therapeutic drugs face hurdles in both the world of lenses and of drugs.
For 20 years, “Therapeutic Topics” has explored ocular disease. Here’s an update on where translational medicine stands today.
Copyright© 2000 - 2015 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.